Skip to Main Content

Paper Details

Methodological Considerations for Comparison of Brand Versus Generic Versus Authorized Generic Adverse Event Reports in the US Food and Drug Administration Adverse Event Reporting System (FAERS).
Clin Drug Investig
9
2017
Author NameAffiliation
Peggy L PeissigBiomedical Informatics Research Center, Marshfield Clinic Research Foundation
Richard L BergBiomedical Informatics Research Center, Marshfield Clinic Research Foundation
  • 1 - 2

Datasets

Release 1.2